Head-To-Head Comparison: Mirion Technologies (MIR) and The Competition

Mirion Technologies (NYSE:MIR) is one of 377 public companies in the “Electronic Equipment, Instruments & Components” industry, but how does it weigh in compared to its competitors? We will compare Mirion Technologies to similar businesses based on the strength of its earnings, risk, dividends, analyst recommendations, institutional ownership, profitability and valuation.

Analyst Recommendations

This is a breakdown of current ratings for Mirion Technologies and its competitors, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mirion Technologies	0	2	7	1	2.90
Mirion Technologies Competitors	2047	7594	10406	658	2.47

Mirion Technologies presently has a consensus price target of $24.88, suggesting a potential upside of 33.28%. As a group, “Electronic Equipment, Instruments & Components” companies have a potential upside of 36.57%. Given Mirion Technologies’ competitors higher possible upside, analysts plainly believe Mirion Technologies has less favorable growth aspects than its competitors.

Risk and Volatility

Mirion Technologies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Comparatively, Mirion Technologies’ competitors have a beta of -0.32, suggesting that their average stock price is 132% less volatile than the S&P 500.

Valuation & Earnings

This table compares Mirion Technologies and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Mirion Technologies	$1.08 billion	$28.80 million	155.53
Mirion Technologies Competitors	$114.91 billion	$166.60 million	5.93

Mirion Technologies’ competitors have higher revenue and earnings than Mirion Technologies. Mirion Technologies is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Mirion Technologies and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mirion Technologies	2.69%	6.82%	3.62%
Mirion Technologies Competitors	-158.15%	-25.69%	-6.84%

Insider & Institutional Ownership

78.5% of Mirion Technologies shares are held by institutional investors. Comparatively, 43.5% of shares of all “Electronic Equipment, Instruments & Components” companies are held by institutional investors. 6.3% of Mirion Technologies shares are held by insiders. Comparatively, 16.0% of shares of all “Electronic Equipment, Instruments & Components” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Mirion Technologies beats its competitors on 9 of the 13 factors compared.

Mirion Technologies Company Profile

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.